Transport of LDL-derived Cholesterol from the NPC1 Compartment to the ER Involves the Trans-Golgi Network and the SNARE Protein Complex by Urano, Yasuomi et al.
Dartmouth College 
Dartmouth Digital Commons 
Dartmouth Scholarship Faculty Work 
10-28-2008 
Transport of LDL-derived Cholesterol from the NPC1 
Compartment to the ER Involves the Trans-Golgi Network and the 











See next page for additional authors Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa 
 Part of the Medical Biochemistry Commons, and the Medical Cell Biology Commons 
Dartmouth Digital Commons Citation 
Urano, Yasuomi; Watanabe, Hiroshi; Murphy, Stephanie R.; Shibuya, Yohei; Geng, Yong; Peden, Andrew; 
Chang, Catherine; and Chang, Ta Yuan, "Transport of LDL-derived Cholesterol from the NPC1 
Compartment to the ER Involves the Trans-Golgi Network and the SNARE Protein Complex" (2008). 
Dartmouth Scholarship. 1182. 
https://digitalcommons.dartmouth.edu/facoa/1182 
This Article is brought to you for free and open access by the Faculty Work at Dartmouth Digital Commons. It has 
been accepted for inclusion in Dartmouth Scholarship by an authorized administrator of Dartmouth Digital 
Commons. For more information, please contact dartmouthdigitalcommons@groups.dartmouth.edu. 
Authors 
Yasuomi Urano, Hiroshi Watanabe, Stephanie R. Murphy, Yohei Shibuya, Yong Geng, Andrew Peden, 
Catherine Chang, and Ta Yuan Chang 
This article is available at Dartmouth Digital Commons: https://digitalcommons.dartmouth.edu/facoa/1182 
Transport of LDL-derived cholesterol from the NPC1
compartment to the ER involves the trans-Golgi
network and the SNARE protein complex
Yasuomi Uranoa, Hiroshi Watanabea, Stephanie R. Murphya, Yohei Shibuyaa, Yong Genga, Andrew A. Pedenb,1,
Catherine C. Y. Changa, and Ta Yuan Changa,2
aDepartment of Biochemistry, Dartmouth Medical School, Hanover, NH 03755; and bGenentech, Inc., South San Francisco, CA 94080
Edited by David W. Russell, University of Texas Southwestern Medical Center, Dallas, TX, and approved September 18, 2008 (received for review
July 31, 2008)
Mammalian cells acquire cholesterol mainly from LDL. LDL enter the
endosomes, allowing cholesteryl esters to be hydrolyzed by acid
lipase. The hydrolyzed cholesterol (LDL-CHOL) enters the Niemann–
Pick type C1 (NPC1)-containing endosomal compartment en route to
various destinations. Whether the Golgi is involved in LDL-CHOL
transport downstream of the NPC1 compartment has not been dem-
onstrated. Using subcellular fractionation and immunoadsorption to
enrich for specific membrane fractions, here we show that, when
parental Chinese hamster ovary (CHO) cells are briefly exposed to
3H-cholesteryl linoleate (CL) labeled-LDL, newly liberated 3H-LDL-
CHOL appears in membranes rich in trans-Golgi network (TGN) long
before it becomes available for re-esterification at the endoplasmic
reticulum (ER) or for efflux at the plasma membrane. In mutant cells
lacking NPC1, the appearance of newly liberated 3H-LDL-CHOL in the
TGN-rich fractions is much reduced. We next report a reconstituted
transport system that recapitulates the transport of LDL-CHOL to the
TGN and to the ER. The transport system requires ATP and cytosolic
factors and depends on functionality of NPC1. We demonstrate that
knockdown by RNAi of 3 TGN-specific SNAREs (VAMP4, syntaxin 6,
and syntaxin 16) reduces >50% of the LDL-CHOL transport in intact
cells and in vitro. These results show that vesicular trafficking is
involved in transporting a significant portion of LDL-CHOL from the
NPC1-containing endosomal compartment to the TGN before its
arrival at the ER.
lipid metabolism  membrane trafficking  vesicular transport
Various bodily cells receive cholesterol mainly via LDL, themajor cholesterol carrier in the blood cholesteryl ester (CE). In
human LDL, cholesteryl linoleate (CL) is the predominant CE.
LDL enters the cells mainly via LDL receptor mediated endocytosis
(1). The endocytosed CE undergoes hydrolysis in an early endo-
somal compartment enriched in acid lipase (2); the cholesterol
released then emerges in endosomes containing the protein Ni-
emann–Pick type C1 (NPC1); from the NPC1 compartment(s), the
LDL-derived cholesterol (LDL-CHOL) moves to various destina-
tions including the plasma membrane (PM) and the endoplasmic
reticulum (ER), etc. (2–4). At the ER, the LDL-CHOL can be
re-esterified to CE by acyl-CoA:cholesterol acyltransferase
(ACAT). There are 2 ACAT isoenzymes, ACAT1 and ACAT2. In
healthy humans, ACAT1 is the main isoenzyme in most cell types,
whereas ACAT2 is the main isoenzyme in intestinal enterocytes (5).
The NPC1 and NPC2 proteins play important roles in LDL-
CHOL transport. NPC1 is a multispan membrane protein localized
to a unique set of endosomes (6, 7); the NPC1-GFP fusion protein
is also present in vesicles budding off from the endosomes (8).
NPC2 is a soluble glycoprotein in the lumen of the late endosomes/
lysosomes (LE/LYS) (9). Both NPC1 and NPC2 bind to cholesterol
(10–15) and may cooperate in endosomal cholesterol transport
(16). Whether the Golgi is involved in LDL-CHOL transport
downstream of the NPC1 compartment has not yet been demon-
strated. To address these issues, we performed pulse–chase exper-
iments in CHO cells with LDL that contained 3H-cholesteryl
linoleate (3H-CL-LDL) to monitor the fate of 3H-LDL-CHOL
liberated in a time-dependent manner. We also developed an in
vitro system that efficiently recapitulates the NPC1-dependent
re-esterification of 3H-LDL-CHOL and used this system to study
the mechanism of LDL-CHOL transport.
Results
Nocodazole or Brefeldin A (BFA) Affects the Re-Esterification and
Efflux of 3H-LDL-CHOL. For most of the studies reported here, we
used a parental CHO cell line, 25RA (17) and a mutant NPC1 cell
line, CT43 cells. 25RA cells contain a mutation in the sterol
regulatory element-binding protein (SREBP) cleavage-activating
protein (SCAP), which constitutively activates SREBP processing
in a sterol-independent manner (18). CT43 cells are NPC1-null cells
derived from 25RA cells (19). Findings made in this cell system are
generally applicable to other cell types (8, 20–22). To monitor the
hydrolysis and transport of 3H-LDL-CHOL liberated from 3H-CL,
we pulse-labeled cells with 3H-CL-LDL for 30 min, then chased the
cells without 3H-CL-LDL for up to 6 h [supporting information (SI)
Fig. S1A]. The percentage of 3H-LDL-CHOL re-esterified by
ACAT1 was used to estimate 3H-LDL-CHOL arrival at the ER. We
also used the availability of labeled sterol to cyclodextrin (CD) in
medium for 10 min to examine the movement of 3H-LDL-CHOL
to the PM (2). The results indicate that in the 25RA cells, the
re-esterification of 3H-LDL-CHOL occurs and increases linearly
with time for up to 6 h, whereas in CT43 cells, re-esterification
remains uniformly deficient (Fig. S1B). As the chase time increases
from 20 min to 2 h, both the percentage re-esterification and the
CD-mediated efflux of 3H-LDL-CHOL increased significantly in
25RA cells but not in CT43 cells (Fig. S1C Middle and Bottom) (2).
The percentage hydrolysis of 3H-CL in CT43 cells was similar to
that of 25RA cells (Fig. S1C Top). These results confirm previous
studies (2, 3) and indicate that in cells lacking functional NPC1, the
movement of LDL-CHOL from the NPC1 compartment to the ER
and to the PM is defective. Using the pulse–chase protocol, we
tested the effects of several compounds (cytochalasin D, wortman-
nin, latrunculin A, nocodazole, BFA, etc.) in 25RA cells for their
ability to interfere with re-esterification or with efflux of 3H-LDL-
CHOL. Because these compounds can also affect the endocytosis/
internalization of the LDL (23), we treated cells with the test
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compound only during the chase but not during the pulse. The
results (Fig. S1D) showed that nocodazole, an agent that disrupts
the microtubules and disintegrates the Golgi within minutes (24),
inhibited the re-esterification and efflux of 3H-LDL-CHOL by
50% (Fig. S1D Middle and Bottom). BFA, which causes fusion of
the Golgi with the ER (25), inhibited efflux to the PM by 40% and
increased re-esterification of 3H-LDL-CHOL by 20%. These
results suggest the involvement of the Golgi in the transport of
LDL-CHOL and are consistent with a previous result using BFA in
human fibroblast cells (26). Other drugs tested did not show
significant effects on re-esterification (data not shown).
Fate of 3H-LDL-CHOL Downstream of the NPC1 Compartment. It is
possible that the effects of nocodazole or BFA on re-esterification
and on efflux of 3H-LDL-CHOL described above may be unrelated
to their ability to disrupt the Golgi function. To further test the
possibility that 3H-LDL-CHOL may move from the NPC1-
containing compartment to the Golgi, we monitored the fate of
3H-LDL-CHOL by performing subcellular fractionation of labeled
cell extracts. We first showed that the cellular organelles are
separated into 6 major fractions (Figs. 1A and S2). NPC1 and NPC2
are principally located in fraction 6 (Fig. S2) but not in fraction 2,
where LE/LYS are located. The same NPC1/NPC2 distribution
patterns occurred in 25RA and WT CHO cell extracts (data not
shown). These results suggest that in CHO cells, NPC1, and NPC2
are located in fractions distinct from the LE/LYS. In our current
work, we designate the endocytic compartment(s) that contain
NPC1 as ‘‘the NPC1 compartment.’’
We next performed pulse–chase experiments and tracked the
labeled cholesterol in various subcellular organelles. The results
(Fig. 1B Left) show that at 0 time, in both the 25RA (blue) and the
CT43 cell extracts (red), 3H-LDL-CHOL was enriched in fractions
4 and 5. At 20-min chase, in 25RA cells, fraction 5, rich in the Golgi
and the early endosome (EE), was enriched in 3H-LDL-CHOL. In
the CT43 cells, 3H-LDL-CHOL was enriched in fraction 2, rich in
LE/LYS, consistent with the previous finding that in mutant NPC1
cells, cellular cholesterol accumulates abnormally within the LE/
LYS (27). At later time point (2 h), in 25RA cell extracts, the
3H-LDL-CHOL appeared in fractions with higher densities (i.e.,
PM, ER, and mitochondria), whereas in CT43 cell extracts, the
3H-LDL-CHOL remained in fraction 2. The distributions of 3H-CL
are very similar in 25RA and CT43 cells (Fig. 1B Right). For 3H-CO,
it appeared as lipid droplets (fractions 1) in 25RA cells after 2 h,
whereas no 3H-CO was produced in CT43 cells (data not shown).
The drug U-18666A causes treated cells to exhibit a phenotype
similar to that of NPC mutants (28). We performed additional
experiments and found that the distribution patterns of 3H-LDL-
CHOL from 25RA cells treated with U-18666A for 24 h were
essentially the same as those of the CT43 cells (Fig. S3A). Addi-
tional experiments show that when 25RA cells were pulsed with
3H-CL-LDL and chased for 2 h, 3H-LDL-CHOL accumulated in
the lower-density endosomal fractions (fractions 2 and 4) in no-
codazole-treated cells during the chase, suggesting that rapid Golgi
disintegration and microtubule disruption may create a transient
NPC1-null phenotype, causing a significant portion of the LDL-
CHOL to accumulate in the endosomes.
LDL-CHOL Moves from the NPC1 Compartment to the TGN. Subcellular
fractionation can provide only partially purified membranes. To
further explore the possibility that Golgi membranes may partici-
pate in LDL-CHOL transport, we used beads coated with antibod-
ies against syntaxin 16, a TGN-protein marker, and performed
selective immunoadsorption (IA) on post-nuclear supernatants
(PNSs) prepared from 25RA cells. Beads coated with nonspecific
rabbit antibodies were used as control. Immunoblot analysis re-
vealed that the anti-syntaxin 16 adsorbed most of the syntaxin 16
and syntaxin 6-positive membranes (Fig. 2A); these membranes also
contained a significant amount of the protein called vesicle-
associated membrane protein 4 (VAMP4) and a small amount of
caveolin-1 (cav1). These results are consistent with previous find-
ings that syntaxin 6, syntaxin 16, and VAMP4 form the soluble
N-ethylmaleimide (NEM)-sensitive factor (NSF) attachment pro-
tein receptor (SNARE) complex at the TGN (29), and that cav1
and syntaxin 6 can form a tight complex in the TGN membranes
(30). The syntaxin 16-positive membranes did not contain any
detectable amount of the early endosomal marker EEA1. We next
performed pulse–chase and monitored the presence of 3H-LDL-
CHOL in the syntaxin 16-rich membranes by IA. The results
indicate (Fig. 2C) that in the 25RA cell extracts, 3H-LDL-CHOL
was associated with the syntaxin 16-rich membranes at 0 time; the
association was increased after the 20-min chase. In the CT43 cell
extracts, however, such association was less at 0 time, and no
increase in association was observed after the 20-min chase. To
expand on this observation, we carried out similar IA experiments
by using beads coated with anti-syntaxin 6-specific antibodies or
with nonspecific rabbit IgGs. We used a pool of OptiPrep fraction
5 membranes isolated from the 25RA cells as the starting materials.
The immunoblot analysis revealed that anti-syntaxin 6 immunoad-
sorbed essentially all of the syntaxin 6-positive membranes; these
membranes also contained a small amount of cav1 but did not
contain EEA1 or NPC1 (Fig. 2B). We next performed a pulse
followed by a 20-min chase in both the 25RA cells and the CT43
cells, isolated OptiPrep fraction 5 from the cell extracts, and carried
out the IAs from these fractions. The results show that in the 25RA
cell extracts, a significant amount of 3H-LDL-CHOL was associated
with the syntaxin 6-rich membranes; whereas in the CT43 cell















































































































Fig. 1. 3H-LDL-CHOL distribution after pulse and various chase periods. (A)
Organelle marker distribution patterns after subcellular fractionation by Opti-
Prep density gradient ultracentrifugation. (B) Cells were pulsed with 3H-CL-LDL
and chased for 0 time (0T) to 2 h; PNSs were fractionated. At 20-min chase time,
3H-LDL-CHOL appears in TGN-rich fraction from 25RA cells but not from CT43
cells. Equal aliquots from each fraction were analyzed for labeled lipids. N
indicates the number of the experiments performed. The data are means  SD.
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results are evidence that a significant portion of the LDL-CHOL is
present in syntaxin 6- and syntaxin 16-rich TGN membranes, and
that the movement of LDL-CHOL to the TGN depends on
functional NPC1.
Transport of LDL-CHOL from Endosomes to the ER in Vitro. We next
used the re-esterification of 3H-LDL-CHOL as a reporter for its
arrival at the ER, and developed an in vitro assay that recapitulates
the NPC1-dependent transport of LDL-CHOL in intact cells. We
found that cells permeabilized with 0.001–0.003% digitonin at 4 °C
for 5–15 min constituted a robust and reproducible in vitro system
for LDL-CHOL transport in 25RA cells (outlined in Fig. 3A). We
loaded the 3H-CL-LDL in intact 25RA cells by performing a pulse,
then prepared semi-intact cells by permeabilizing the cell mono-
layers. We then added various factors, including rat liver cytosol,
ATP/GTP, and oleoyl-CoA (as a substrate by ACAT1 in vitro),
individually or in combination, and monitored the re-esterification
of 3H-LDL-CHOL with time. We also conducted parallel experi-
ments in AC29 cells. AC29 cells are mutant cells derived from
25RA cells, but AC29 cells lack ACAT1 (31). As shown in Fig. 3B
Top, after incubation at 37 °C for 3 h, the hydrolysis of 3H-CL-LDL
significantly increased in both 25RA and AC29 cells; however,
significant re-esterification of 3H-LDL-CHOL occurred in 25RA
cells but not in AC29 cells (Fig. 3B Bottom), demonstrating the
dependency of re-esterification on ACAT1. Omitting ATP/GTP or
cytosolic factors from the incubation mixture severely diminished
re-esterification activity; omitting oleoyl-CoA partially reduced the
activity (Fig. 3B Bottom). A separate experiment demonstrated that
adding GTPS (a nonhydrolyzable analog of GTP) also diminished
the re-esterification activity in reconstituted 25RA cell system (data
not shown). Additional experiments (Fig. 3C) show that after
incubating at 37 °C for 1 h, 3H-LDL-CHOL re-esterification in
reconstituted 25RA cell system increased with time for up to 3 h.
By contrast, in reconstituted CT43 cell system, re-esterification
activity remained undetectable. This demonstrates that the re-
esterification of 3H-LDL-CHOL in the reconstituted system de-
pends on functional NPC1. In reconstituted 25RA cell system, 3%
re-esterification occurred in 2 h and 5% in 3 h (Fig. 3C); in intact
25RA cells, 12% re-esterification occurred in 2 h, and 20% in 3 h
(Fig. S1B). Thus, the efficiency of the reconstituted system is
20–25% of that observed in intact cells. Vesicular trafficking
requires soluble ATPases present in the cell cytosol. NEM inhibits
ATPases and disrupts vesicular trafficking events in vitro. We tested
the possible involvement of soluble ATPases in our in vitro system.
The results show that NEM abolished the activity of the cytosol,
whereas simultaneous inclusion of DTT partially prevented the
inhibitory action of NEM (data not shown).
The results described in Fig. 3 B and C suggest that the movement
of LDL-CHOL from the NPC1 compartment to the ER in vitro
involves vesicular transport. Numerous protein cargos undergo
retrograde transport from the EE/recycling endosomes to the TGN
by vesicular trafficking (32). To test this hypothesis that the trans-
port of LDL-CHOL from the NPC1 compartment to the TGN may
involve a similar mechanism, we performed an LDL-CHOL trans-
port assay in reconstituted 25RA and CT43 cell systems for 2 h, then
used the labeled PNSs to perform IA experiments, using anti-
syntaxin 6 or nonspecific antibodies as the immunoprobes. The
results (Fig. 3D) show that a significant increase in association
between 3H-LDL-CHOL and the syntaxin 6-rich membranes oc-
curred in the reconstituted 25RA cells but not in the reconstituted
CT43 cells. An additional experiment (Fig. 3E) showed that in
reconstituted 25RA cells, for 3H-LDL-CHOL to be associated with
























































































































































Fig. 2. Association of 3H-LDL-CHOL with syntaxin 6-rich and syntaxin 16-rich
membranes in intact 25RA cells. The 25RA and CT43 cells were pulsed with
3H-CL-LDL and chased in Medium A for 20 min. (A and C) The PNSs were
immunoadsorbed with rabbit anti-syntaxin 16 (antiS16) antibodies or non-
specific rabbit antibodies (CNTL). (B and D) The PNSs were fractionated by
OptiPrep density gradient ultracentrifugation; the syntaxin 6-rich fractions
(fraction 5) were isolated and immunoadsorbed with rabbit anti-syntaxin 6
(antiS6) antibodies or nonspecific rabbit antibodies (CNTL). (A and B) Associ-
ated proteins were analyzed by immunoblot using appropriate antibodies as
indicated. The 25RA cells were used. (C and D) 3H-LDL-CHOL counts in the
eluates were analyzed after lipid extraction and TLC. Values are presented as
the percentage of total labeled sterol (C). The data are means  SD from 2
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Fig. 3. Cholesterol transport assay in semi-intact cells. (A) Procedure used to
conduct the LDL-CHOL transport assay in vitro. (B) Hydrolysis and re-
esterification in the presence or absence of ATP/GTP, or rat liver cytosol, or
oleoyl-CoA as indicated, for 3 h at 37 °C. (C) Re-esterification in semi-intact
25RA or CT43 cells during the 3-h incubation time. (D and E) 3H-LDL-CHOL
associated with syntaxin 6-rich membranes in semi-intact 25RA or CT43 cells
with or without incubation for 2 h (D) or in semi-intact 25RA cells with or
without ATP or rat liver cytosol during incubation as indicated (E). Values are
presented as the percentage of total labeled sterol. Data are means  SD from
2 experiments. **, P  0.01 by Student’s t test.








required, suggesting that transport of LDL-CHOL from the NPC1
compartment to the TGN involves a vesicular mechanism.
Knocking Down VAMP4/Syntaxin 6/Syntaxin 16 Diminishes the Re-
Esterification of 3H-LDL-CHOL in CHO Cells. The SNARE complex
VAMP4/syntaxin 6/syntaxin 16/Vti1a at the TGN plays an impor-
tant role in mediating the transport of various proteins between the
EE/recycling endosomes and the TGN (29). The same SNARE
complex may also participate in the transport of LDL-CHOL to the
TGN. We took the siRNA knockdown (KD) approach to investi-
gate this possibility. We cloned the Chinese hamster VAMP4,
syntaxin 6 and syntaxin 16 cDNAs by PCR amplification (Fig. S4).
To guard against possible off-target effect(s) caused by individual
siRNAs, we used 2 or 3 siRNAs against different regions for each
of these genes (2 for VAMP4, 2 for syntaxin 6, and 3 for syntaxin
16) and monitored the effects of each of these siRNAs on the target
protein expression level and on 3H-LDL-CHOL transport. We first
transfected the 25RA or CT43 cells with siRNA targeted against
VAMP4 (iV41 or iV42), or with a control siRNA (CNTL). Immu-
noblot analyses show that 48 h after transfection, the iV4s reduced
VAMP4 protein expression by 90% (iV41) or 95% (iV42) (Fig.
S5A). The KD of VAMP4 by iV4 did not significantly affect the
protein expressions of syntaxin 6, syntaxin 16, EEA1, cav1, NPC1,
-actin, or ACAT1 (Fig. S5A). We then performed the LDL-
CHOL trafficking assays in intact cells after VAMP4 KD. The
results show that the re-esterification of 3H-LDL-CHOL in iV4
treated 25RA cells was reduced by 13% or 27% (Fig. 4A Left). The
re-esterifications in CT43 cells with or without iV4 treatment were,
as expected, much lower (Fig. 4A Right). The hydrolysis was slightly
diminished by VAMP4 KD in 25RA cells but not in CT43 cells
(data not shown). Additional results show that VAMP4 KD did not
affect the transport of 3H-LDL-CHOL to the PM in 25RA cells
(Fig. 4C), suggesting that VAMP4 is involved in transporting
LDL-CHOL to the ER but not in transporting it to the PM. We next
performed the VAMP4 KD experiments in WT CHO cells. The
results show that iV41 or iV42 also efficiently reduced the VAMP4
protein expression in treated WT cells, without affecting the
expression of other proteins examined (Fig. S5A). The re-
esterification of 3H-LDL-CHOL in iV41 or iV42 treated WT cells
was reduced by 11% or 28% (Fig. 4B Left). In WT cells treated with
U-18666A, the re-esterification of 3H-LDL-CHOL remained very
low with or without iV4 treatment (Fig. 4B Right). We next asked
whether the role of VAMP4 in LDL-CHOL transport could be
demonstrated in our in vitro system. We performed VAMP4 KDs
in 25RA cells, and then conducted the in vitro assay for transport
of LDL-CHOL to the ER. The results show that VAMP4 KD (with
iV41 or iV42; Fig. 4D) reduced the re-esterification of 3H-LDL-
CHOL by 42% or 58%. To test whether VAMP4 is involved in the
trafficking of LDL-CHOL to the TGN, we treated 25RA cells with
an iV4 or with a CNTL siRNA for 48 h, performed the pulse, then
chased for 30 min in intact cells (Fig. 4E) or chased in the
reconstituted cell system for 2 h (Fig. 4F), then used the PNSs to
perform IA experiments. The results show that a significant in-
crease in association of 3H-LDL-CHOL to the syntaxin-6 rich
membranes occurred in CNTL treated intact cells or reconstituted
cell system, but not in iV4 treated intact cells or reconstituted cell
system (Fig. 4 E and F). These results suggest that VAMP4 is
involved in transporting LDL-CHOL to the TGN.
We next performed similar siRNA experiments on syntaxin 6. In
the 25RA, CT43, and WT cells, after 72-h incubation, the 2 syntaxin
6 siRNAs (iS61 and iS62) reduced the syntaxin 6 expression by
95% without significantly affecting the expression of several
proteins examined (Fig. S5B). The results of the LDL-CHOL
trafficking assay in intact cells showed that iS61 or iS62 reduced the
re-esterification of 3H-LDL-CHOL by 31% or 17% in 25RA cells
(Fig. S6A Left) and by 57% or 29% in WT cells, respectively (Fig.
S6B Left). KD of syntaxin 6 did not affect the transport of
3H-LDL-CHOL to the PM in 25RA cells (Fig. S6C). In the
reconstituted 25RA cell system, syntaxin 6 KD (with iS61 or iS62)
reduced the re-esterification of 3H-LDL-CHOL by 48% or 32%
(Fig. S6D).
We next performed siRNA KD of syntaxin 16. In 25RA, CT43,
or WT cells, after 72-h incubation, the 3 different syntaxin 16
siRNAs reduced syntaxin 16 expression by 50% (iS161), 80%
(iS162), or 70% (iS163) of the control value (Fig. S5C). Syntaxin 6
expression was also modestly reduced by the syntaxin 16 KD, in
agreement with a previous report (33). In 25RA cells, the re-
esterification of 3H-LDL-CHOL was reduced by 42% (iS161), 73%
(iS162), or 58% (iS163) (Fig. 5A Left). In WT cells, the re-
esterification of 3H-LDL-CHOL was reduced by 48% (iS161), 56%
(iS162), or 58% (iS163) (Fig. 5B Left). Syntaxin 16 KD in 25RA cells
also did not significantly affect the transport of 3H-LDL-CHOL to
the PM (Fig. 5C). In the reconstituted 25RA cell system, syntaxin
16 KD (with iS162 or iS163) reduced the re-esterification of
3H-LDL-CHOL by 50% or 45% (Fig. 5D). Together, these results
implicate VAMP4/syntaxin 6/syntaxin 16 in the LDL-CHOL trans-
port pathway in both the 25RA and WT CHO cell lines.
Discussion
Previously, using filipin as a probe for cholesterol, Blanchette–
Mackie and colleagues (34) performed cytochemical freeze–
fracture electron microscopy and showed that cholesterol content
increased in the Golgi when human fibroblasts were incubated with
LDL for 24 h, suggesting the involvement of the Golgi in LDL-
CHOL transport. However, because of the low sensitivity of the
filipin-staining method, the LDL incubation time was necessarily
prolonged; this and other technical difficulties prevented the in-
vestigators from determining the role of the Golgi in LDL-CHOL





























































































































































































































































Fig. 4. VAMP4 KDs reduce 3H-LDL-CHOL transport in intact 25RA, WT cells,
or reconstituted 25RA cell system. The 25RA, CT43, or WT cells were trans-
fected with control (CNTL) or VAMP4 (iV41, iV42) siRNA and incubated for 48 h
then pulsed with 3H-CL-LDL. (A) Re-esterification in 25RA or CT43 cells; chase
time, 3 h. Data are means  SD from 3 experiments. (B) re-esterification in WT
cells treated with or without 0.3 M U-18666A; chase time: 6 h. Data are
means  SD from 3 experiments. (C) Efflux to CD in 25RA cells; chase time, 3 h.
Data are means  SD from 2 experiments. (D) Re-esterification in reconsti-
tuted 25RA cell system. Incubation time, 3 h. Data are means  SD from 3
experiments. (E and F) 3H-LDL-CHOL associated with syntaxin 6-rich mem-
branes in intact 25RA cells at 0T or after 30-min chase (E), in reconstituted 25RA
cell system at 0T, or after 2-h incubation (F). Data are means  SD from 2
experiments. *, P  0.05; **, P  0.01 by Student’s t test.
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monitored the early itinerary of 3H-labeled LDL-CHOL in parental
(25RA) and mutant NPC1 (CT43) cells by various biochemical
means, and developed an in vitro system to monitor the transport
of LDL-CHOL from the NPC1 compartment to the ER. We also
performed siRNA KD experiments and showed that VAMP4,
syntaxin 6, and syntaxin 16 participate in LDL-CHOL transport to
the ER, and that VAMP4 is involved in moving LDL-CHOL from
the NPC1 compartment to the TGN (Fig. 4 E and F). We conclude
that the transport of a significant portion of LDL-CHOL from the
NPC1 compartment to the ER involves vesicular trafficking and the
SNARE complex to the TGN.
Our results suggest that VAMP4/syntaxin 6/syntaxin 16 are not
directly involved in translocating LDL-CHOL to the PM for sterol
efflux. Syntaxin 6 is involved in the rapid delivery of sphingolipids
and cellular cholesterol from the TGN to cholesterol rich regions in
the PM (i.e., caveolae) (30). In a mammalian cell, within 2–3 h, the
initial cellular fates of CHOL newly derived from LDL and that
derived from recently synthesized sterols are distinct (28, 39); at
steady state, cellular cholesterol can rapidly circulate (within min-
utes) among certain compartments (40–42). Syntaxin 6 may be
involved in moving the circulating CHOL (but not newly derived
LDL-CHOL) to the PM.
Our results show that neither VAMP4, syntaxin 6, nor syn-
taxin 16 KD could reduce LDL-CHOL transport by 70% (Figs.
4 and 5 and S6), suggesting that more than 1 SNARE complex
may be involved in the vesicular transport of LDL-CHOL from
the endosomes to the TGN, similarly to what has been demon-
strated in protein transport studies (33, 43). Assuming nocoda-
zole acts by rapidly disintegrating the TGN, the results presented
in Fig. S1D suggest that the endosome to TGN pathway may be
responsible for 50% of the total LDL-CHOL transport to the ER
or to the PM in 25RA cells. The results presented in Fig. 5 A and
B suggest that the TGN-specific SNARE syntaxin 16 may be
involved in transporting 60–70% of the LDL-CHOL from the
endosomes to the ER. Both estimates suggest that in CHO cells,
other mechanisms are also involved in transporting LDL-CHOL.
In yeast, certain oxysterol binding proteins may be involved in
NPC-dependent sterol transport in a nonvesicular manner (44).
Further experiments will be required to test the relative impor-
tance of vesicular and non-vesicular mechanisms for transporting
cholesterol from different sources in different cell types.
We propose a working model to summarize a pathway for
LDL-CHOL transport (Fig. S7): the endocytosed CE in LDL
undergoes hydrolytic cleavage in a specialized EE; the CHOL
liberated enters the NPC1-containing endosomes. By mecha-
nism(s) yet to be revealed, cholesterol-rich vesicles form; these
vesicles move to the TGN by vesicular trafficking that involves
the SNARE proteins VAMP4, syntaxin 6, and syntaxin 16. From
the TGN, the LDL-CHOL moves to the ER for re-esterification
by ACAT1, or moves to the PM. Additional trafficking mecha-
nism(s) also exist to transport LDL-CHOL. For example, in
mutant NPC cells, overexpressing Rab9, a small GTPase en-
riched in the LE/LYS, efficiently rescues the LE/LYS cholesterol
accumulation phenotype (45, 46). The following scenario may
occur: In NPC1-null cells, LDL-CHOL enters the endosomes but
cannot exit normally. It rapidly moves to the LE/LYS where it
accumulates. A Rab9-dependent NPC1-independent cholesterol
translocation pathway occurs between the LE/LYS and the TGN
but operates at low efficiency. Overexpressing the Rab9 protein
increases the efficiency of this pathway and bypasses the need for
NPC1. It will be important to further dissect the molecular
machineries involved in transporting LDL-CHOL. The avail-
ability of the reconstituted cell system described in this work
should facilitate these studies.
Materials and Methods
LDL-Derived Cholesterol Trafficking Assays. The 25RA and CT43
cells were cultured in 6-well dishes in Medium A for 2–3 days,
pulsed with 30 g/ml 3H-CL-LDL in Medium A for 30 min at
37 °C, and chased in Medium A for 0–6 h (Fig. S1 A). The labeled
lipids were extracted and analyzed on silver nitrate impregnated
TLC plates (47); the percentage hydrolysis of 3H-CL and the
percentage re-esterification of 3H-LDL-CHOL were calculated
as described (2). To conduct the cholesterol eff lux experiments,
cells were incubated with 4% 2-hydroxypropyl--CD in Medium
D at 37 °C during the last 10 min of the chase period (2).
Previously, we employed a ‘‘release of a temperature block’’
method to monitor the fate of 3H-LDL-CHOL (2). Control
experiments show that the pulse–chase protocol described here
reproduces all of the findings described in ref. 2. The WT cells
were cultured in Medium A for 2 days, switched to Medium D
with or without 0.3 M U-18666A for 24 h, and chased in
Medium A with or without U-18666A.
Immunoadsorption. Four hundred microliters of PNS material
mixing with 200 l of 60% OptiPrep solution, cleared by
centrifuging at 15,000  g for 10 min, was used as the starting
material. Alternatively, PNS was subject to 5–25% OptiPrep
gradient ultracentrifugation for 3 h; fraction 5 was used as the
starting material. 150 L of the starting material were incubated
for 1.5 h on ice with 150 mM NaCl and 2 L of anti-syntaxin 16
antiserum or 2 g of anti-syntaxin 6 IgG, or the same amount of
nonspecific rabbit antiserum or IgGs in final vol. of 200 L; the
mixtures were incubated for 30 min on ice with 40 L of Macs
Protein A MicroBeads (Miltenyi Biotec), loaded onto the Col-
umn, the flowthrough (FT) was collected. After washing the
beads with 800 L of HB containing 150 mM NaCl, the proteins
bound to the beads were eluted with 100 L of 1  SDS/PAGE
sample buffer. Equal aliquots of the total input, eluate and FT
samples were analyzed by immunoblots by using appropriate
antibodies. The 3H-labeled lipids bound to beads were collected
by eluting beads with 500 L of chloroform/methanol (2:1) and
analyzed by TLC (2).
LDL-CHOL Transport Assay in Digitonin-Permeabilized Semi-Intact
Cells. The assay was based on the assay developed to monitor
protein transport between organelles in vitro (29). Cells were
grown in Medium A in 6-well dishes, labeled with 30 g/ml

















































































































































































Fig. 5. Syntaxin 16 KDs reduce 3H-LDL-CHOL re-esterification in intact 25RA,
WT cells, or reconstituted 25RA cell system. The 25RA, CT43, or WT cells were
transfected with control (CNTL) or syntaxin 16 (iS161-iS163) siRNA and incu-
bated for 72 h, then pulsed with 3H-CL-LDL. (A) Re-esterification in the 25RA
or CT43 cells; chase time, 3 h. Data are means  SD from 3 experiments. (B)
Re-esterification in the WT cells treated with or without 0.3 M U-18666A;
chase time, 6 h. Data are means  SD from 2 experiments. (C) Efflux to CD in
the 25RA cells; chase time, 3 h. Data are means  SD from 3 experiments. (D)
Re-esterification in reconstituted 25RA cell system. Incubation time, 3 h. Data
are means  SD from 2 experiments. **, P  0.01 by Student’s t test.








washed twice with ice-cold transport buffer (TB, 25 mM Hepes-
KOH, pH 7.2, 115 mM potassium acetate, 2.5 mM MgCl2), and
incubated for 10 min with 20 g/ml (0.002%) digitonin in TB at
4 °C. The permeabilized cells were washed with ice-cold TB and
incubated in TB for 20 min at 4 °C to remove the residual cytosol.
Over 99% of cells become permeabilized, as assessed by trypan
blue staining. The semi-intact cells were incubated at 37 °C in
500 L of TB with the following reagents: 200 g of rat liver
cytosol (Xenotech), the ATP regeneration system (1 mM ATP,
10 mM creatine phosphate (Alfa Aesar), 10 units/ml creatine
phosphokinase, 0.1 mg/ml BSA, 10 mM Hepes-KOH, pH 7.2),
250 M GTP, 50 M oleoyl-CoA, and 0.8 mM magnesium
acetate, for various times. After incubation, the reaction was
stopped by adding 500 L of 0.4 M NaOH, and the cells were
incubated for 30 min at room temperature. Labeled lipids were
extracted and analyzed by TLC. To monitor the transport of
LDL-CHOL to syntaxin 6-rich region in vitro, the semi-intact
cells with or without incubation for 2 h in transport reaction mix,
as indicated, were scraped and homogenized by using a glass
homogenizer (with 20 strokes), followed by centrifugation at
16,000  g for 10 min in 20% OptiPrep. The resultant PNSs were
incubated with appropriate antibodies as indicated, then incu-
bated with Macs Protein A MicroBeads, and processed in the
same manner as the immunoadsorption procedure described
above.
Additional materials and methods are described in SI Mate-
rials and Methods.
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